BAILARD, INC. - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 216 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.93 and the average weighting 0.1%.

Quarter-by-quarter ownership
BAILARD, INC. ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$390,000
+12.1%
4,200
-17.6%
0.01%0.0%
Q2 2021$348,000
-41.2%
5,100
-33.8%
0.01%
-55.6%
Q4 2020$592,000
-24.6%
7,700
-26.7%
0.03%
-34.1%
Q3 2020$785,000
+13.4%
10,500
-4.5%
0.04%
+5.1%
Q2 2020$692,000
+49.8%
11,0000.0%0.04%
+18.2%
Q1 2020$462,000
-85.6%
11,000
-88.8%
0.03%
-81.8%
Q4 2019$3,213,000
+1.7%
98,000
+42.0%
0.18%
-5.2%
Q3 2019$3,158,000
-8.7%
69,000
+16.9%
0.19%
-9.5%
Q2 2019$3,459,000
+15.1%
59,000
-11.9%
0.21%
+13.4%
Q1 2019$3,004,000
+57.4%
67,000
+36.7%
0.19%
+44.2%
Q4 2018$1,909,000
-15.3%
49,0000.0%0.13%
-2.3%
Q3 2018$2,255,000
-7.7%
49,000
-47.3%
0.13%
-9.0%
Q2 2018$2,443,000
-29.3%
93,000
-35.0%
0.14%
-34.1%
Q1 2018$3,457,000
+25.6%
143,000
+76.5%
0.22%
+27.2%
Q4 2017$2,752,00081,0000.17%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Prosight Management, LP 163,133$7,467,0004.14%
PFM Health Sciences, LP 2,271,536$103,968,0003.07%
Partner Investment Management, L.P. 28,877$1,322,0002.26%
Atika Capital Management LLC 181,000$8,284,0001.74%
DAFNA Capital Management LLC 93,942$4,300,0001.62%
Asymmetry Capital Management, L.P. 16,272$745,0001.60%
First Light Asset Management, LLC 190,838$8,735,0001.32%
Perceptive Advisors 953,129$43,624,0001.18%
Rhenman & Partners Asset Management AB 155,000$7,094,0000.89%
Opus Point Partners Management, LLC 9,770$447,0000.81%
View complete list of ARENA PHARMACEUTICALS INC shareholders